Jay Y. Spiegel
- Oncology top 10%
- CAR-T cell therapy research 21
-
- Lymphoma Diagnosis and Treatment 4
-
- Cancer Genomics and Diagnostics 5
-
- Virus-based gene therapy research 2
-
- Viral Infectious Diseases and Gene Expression in Insects 3
- CRISPR and Genetic Engineering 3
-
- Advancements in Semiconductor Devices and Circuit Design 3
-
- Biomedical Ethics and Regulation 2
- Co-authors
- David B. MiklosNasheed HossainMatthew J. FrankSaurabh DahiyaMichael D. JainAaron P. RapoportFrederick L. LockeJuliana Craig
- Journals
- Journal of Clinical Oncology (4 papers)SHILAP Revista de lepidopterología (1 paper)Blood (11 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Jay Y. Spiegel
26 papers receiving 360 citations
Peers
Comparison fields: 5 of 51
- Oncology 243
- Pathology and Forensic Medicine 102
- Cancer Research 67
- Hematology 37
- Genetics 31
Countries citing papers authored by Jay Y. Spiegel
This map shows the geographic impact of Jay Y. Spiegel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Y. Spiegel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Y. Spiegel more than expected).
Fields of papers citing papers by Jay Y. Spiegel
This network shows the impact of papers produced by Jay Y. Spiegel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Y. Spiegel. The network helps show where Jay Y. Spiegel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jay Y. Spiegel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 12 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 10 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 87 | |
| 14 | 2020 | 4 | |
| 15 | 2019 | 14 | |
| 16 | 2019 | 13 | |
| 17 | 2019 | 14 | |
| 18 | 2018 | 48 | |
| 19 | 2018 | 79 | |
| 20 | 2018 | 9 |
About Jay Y. Spiegel
Jay Y. Spiegel is a scholar working on Oncology, Genetics and Hematology, having authored 28 papers that have together received 361 indexed citations. Recurring topics across this work include CAR-T cell therapy research (21 papers), Cancer Genomics and Diagnostics (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), CRISPR and Genetic Engineering (3 papers), Advancements in Semiconductor Devices and Circuit Design (3 papers), Virus-based gene therapy research (2 papers) and Biomedical Ethics and Regulation (2 papers). The work is most often cited by research in Oncology (243 citations), Pathology and Forensic Medicine (102 citations) and Cancer Research (67 citations). Jay Y. Spiegel has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include David B. Miklos, Nasheed Hossain, Matthew J. Frank, Saurabh Dahiya, Michael D. Jain, Aaron P. Rapoport, Frederick L. Locke, Juliana Craig, Crystal L. Mackall and Katherine A. Kong. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.